Z-1371-2016 Class II Terminated
FDA device recall Z-1371-2016 was initiated by Maquet Cardiovascular Us Sales, Llc on Feb 23, 2016 and is designated Class II. Reason for recall: Maquet Cardiopulmonary (MCP) is conducting a voluntary recall based on the potential risk of exposure to endotoxin for various products. The recall status is terminated (terminated Sep 25, 2019). Affected quantity: 72,000 units in total.
Recall details
- Product Type
- Devices
- Report Date
- Apr 20, 2016
- Initiation Date
- Feb 23, 2016
- Termination Date
- Sep 25, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 72,000 units in total
Product description
QUADROX-i oxygenators Custom tubing packs for the oxygenator
Reason for recall
Maquet Cardiopulmonary (MCP) is conducting a voluntary recall based on the potential risk of exposure to endotoxin for various products.
Distribution pattern
US Nationwide Distribution.
Code information
All sizes and membrane types of QUADROX-i oxygenators, QUADROX-i(D) Adult, Small Adult, Pediatric and Neonatal with SOFTLINE and BIOLINE Coating; BE-HMOD xxxxx, BEQ-HMO xxxxx, BEQ-HMOD xxxxx, BO-VKMO xxxxx, HMO xxxxx, HMOD xxxxx, VKMO xxxxx, X HMO xxxxx U, X HMOD 30000 U, X VKMO xxxxx U, and X 1895. QUADROX-iR with SOFTLINE and BIOLINE Coating; XVIVO HMO 70100
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1371-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026